Clinical Trial Update: A Study of Granexin® Gel for the Reduction of Scar Formation in Surgical Wounds Following Bilateral Anchor Incision Breast Surgery [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 study evaluating Granexin Gel to reduce scar formation after bilateral anchor incision breast surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Reconstruction
• Mammoplasty
• Scar
• Scarring

Drugs mentioned

• Granexin Gel

Snippet

Sponsor: Xequel Bio, Inc. | Conditions: Mammoplasty, Scarring | Phase 2, Phase 3 | Status: COMPLETED